Actor portrayals.

If it’s COVID,


PAXLOVID is a prescription treatment for mild-to-moderate COVID-19 in adults who are at high risk for progression to severe COVID-19, including hospitalization or death.

Feel sick? Connect to a doctor via telehealth

‎‎PAXLOVID is also authorized for certain people under an Emergency Use Authorization. Learn more.

Who can take PAXLOVID?

As much as we all wish COVID‑19 were a thing of the past, it’s not. It’s still very much here and making some people very sick, especially people who are at high risk for progression to severe COVID‑19.

PAXLOVID is an FDA-approved oral prescription medication that can treat adults who:

have mild-to-moderate COVID‑19, and
have had symptoms for 5 days or fewer, and
have a high-risk factor for progression to severe COVID‑19, such as being 50 years or older or having certain health conditions and/or lifestyle factors.

PAXLOVID is not approved for use as pre-exposure or post-exposure treatment for prevention of COVID‑19. There are certain medications that should not be taken with PAXLOVID. Talk to your healthcare professional to see if PAXLOVID is right for you.

Approximately 75% of American adults have at least one risk factor for progression to severe COVID‑19. You could be one of them.

Some of the most common risk factors for progression to severe COVID‑19 include:

  • Age of 50+ years
  • Certain health conditions and diseases, such as heart disease and diabetes
  • Being overweight or obese
  • Mental health conditions
  • Lifestyle factors, such as smoking
  • Physical, mental, and developmental disabilities

Want to learn more about PAXLOVID?

PAXLOVID is a 5-day oral prescription treatment for COVID‑19.

Learn more about how to take PAXLOVID

A trial compared the risk of COVID‑19–related hospitalization or death in people treated with PAXLOVID vs placebo.

Learn about the PAXLOVID clinical trial

It’s important to understand the risks and possible side effects of PAXLOVID before starting treatment.

See safety and possible side effects

Be prepared for COVID‑19.

If you’re at high risk for progression to severe COVID‑19, it’s important to be ready to take action if you have COVID‑19. Fill out this COVID‑19 Preparedness Plan so you can be ready to speak with a healthcare professional about PAXLOVID.

Download the COVID‑19 Preparedness Plan

Paxlovid Be Prepared

How to verify your tablets are authentic

PAXLOVID must be prescribed by a licensed healthcare professional and supplied by a government-approved pharmacy or medical facility.

Authentic PAXLOVID, from Pfizer Inc., will include the Pfizer name on the label and will be packaged in several aluminum push-through blister cards. Individual doses are not for sale. PAXLOVID will be packaged in a carton. The carton has a colorless, glossy coating that contains a repeated pattern of the Pfizer name and logo all over, and these repeating features are seen in a contrasting matte finish.

PAXLOVID consists of tablets for a 5-day oral treatment regimen, with morning and evening doses.

NOTE: If you are a patient with moderate kidney disease, you may receive a carton with daily blister cards that have been modified to ensure you receive the correct dose.

To help determine whether the tablets are authentic, look for specific text on each side of the tablets

Embossed Text
Front: 3CL | Back: PFE
ritonavir, manufactured by AbbVie
Front: NK | Back: No text

For packaging options and information, see the Patient PAXLOVID Packaging Flashcard here.

Pfizer is committed to patient safety and ensuring that people have accurate information about PAXLOVID, including how it is accessed and administered. We are actively monitoring for fraudulent offers of illegitimate PAXLOVID to protect patients from products that might be dangerous and lead to serious and life-threatening harm.

If you suspect the product you have received may be counterfeit, contact us at 1-800-438-1985 or visit

For more information

Contact one of the following groups:

For medical information visit or call 1-800-438-1985

For general product inquiries call 1‑8‍77‑C19‑PACK (1-877-219-7225)